Bipolar exfoliation and in-situ deposition of high-quality reduced graphene
US-11352703-B2 · Jun 7, 2022 · US
US12130286B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12130286-B2 |
| Application number | US-202217806109-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 9, 2022 |
| Priority date | Jun 9, 2022 |
| Publication date | Oct 29, 2024 |
| Grant date | Oct 29, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Biosensors capable of detecting certain biomarkers (e.g., platelet-derived growth factor-BB (PDGF-BB)), as well as methods of fabricating the same and methods of using the same, are provided. The biosensors can be disposable and/or label-free. Electrochemical bipolar exfoliation can be used to exfoliate, reduce, and deposit (in a single step) graphene nanosheets on a desired substrate (e.g., an electrode). Affinity aptamers can be immobilized on the graphene nanosheets disposed on the substrate.
Opening claim text (preview).
What is claimed is: 1. A biosensor for detecting a biomarker, the biosensor comprising: an electrode comprising a metal; reduced graphene oxide (rGO) disposed on the electrode, the rGO comprising graphene nanosheets; and a plurality of aptamers disposed on the rGO, the plurality of aptamers being configured to bind to the biomarker, the plurality of aptamers being directly immobilized on the graphene nanosheets without any mediator or linking layer disposed therebetween, the rGO covering at least 90% of an upper surface of the metal of the electrode, and the rGO having a vertically aligned structure. 2. The biosensor according to claim 1 , the electrode further comprising a substrate on which the metal is disposed. 3. The biosensor according to claim 2 , the substrate being a polymer. 4. The biosensor according to claim 3 , the substrate being polyethylene terephthalate (PET). 5. The biosensor according to claim 1 , the metal being gold (Au). 6. The biosensor according to claim 1 , the metal being stainless steel (SS). 7. The biosensor according to claim 1 , the biomarker being a cancer biomarker. 8. The biosensor according to claim 1 , the biomarker being platelet-derived growth factor-BB (PDGF-BB). 9. The biosensor according to claim 1 , the biosensor being label-free. 10. The biosensor according to claim 1 , the biosensor being disposable. 11. The biosensor according to claim 1 , the biosensor having a lower limit of detection for the biomarker of less than 1 picomolar (pM). 12. A biosensor for detecting a biomarker, the biosensor comprising: an electrode comprising a metal; reduced graphene oxide (rGO) disposed on the electrode, the rGO comprising graphene nanosheets; and a plurality of aptamers disposed on the rGO, the plurality of aptamers being configured to bind to the biomarker, the biomarker being platelet-derived growth factor-BB (PDGF-BB), the rGO covering at least 90% of an upper surface of the metal of the electrode, the rGO having a vertically aligned structure, the biosensor being label-free, the biosensor being disposable, the biosensor having a lower limit of detection for the biomarker of less than 1 picomolar (pM), the plurality of aptamers being directly immobilized on the graphene nanosheets without any mediator or linking layer disposed therebetween, and the electrode comprising either feature a) or feature b): a) the electrode comprising a substrate on which the metal is disposed, the metal being gold (Au), and the substrate being polyethylene terephthalate (PET); or b) the metal of the electrode being stainless steel (SS).
involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites · CPC title
Platelet-derived growth factor [PDGF] · CPC title
being a hybridisation with immobilised receptors (using a FET type sensor G01N27/4145; concerning the hybridisation C12Q1/68) · CPC title
at least partially made of carbon · CPC title
Electrodes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.